ArticleMicrobiology spectrum2025
Evaluation of an interferon-gamma release assay for early detection of lumpy skin disease virus infection and vaccination in cattle.
Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Selective culling and the potential persistence of lumpy skin disease in cattle herds: insights from a mechanistic transmission model.Veterinary research · 2026Article
- Humoral and cytokine responses to a heterologous goatpox vaccine in Mithun (Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lumpy skin disease virus (LSDV) causes a nodular dermatitis in cattle and has high economic consequences in affected areas. Detection of LSDV exposure mostly relies on the humoral immune response, while the cell-mediated immune (CMI) response, an important hallmark of the immune reaction to LSDV, is neglected. We collected samples during 3 weeks post-vaccination of cattle with a Neethling-based live attenuated vaccine (LAV) and during 4 weeks post-LSDV infection under experimental conditions to i) investigate the development of the CMI response, ii) optimize an interferon-gamma release assay (IGRA) by comparing two matrices (whole blood and PBMCs) and different stimuli, and iii) evaluate the usefulness of an IGRA for detection of infection and vaccination. The CMI response to the Neethling LAV was detectable in all animals from 10 days post-vaccination, and importantly, preceded the detection of antibodies. A uniform CMI response to infection was already detected at its plateau level at 7 days post-infection in all animals and also preceded antibody detection. Whole blood and PBMCs allowed efficient IFN-γ secretion, but the IFN-γ response was significantly higher in PBMCs. Heat-inactivated antigen proved to be the stimulus of choice for LSD IGRA, providing increased sensitivity of the test and allowing its performance under BSL2 conditions. Under several conditions, LSDV IGRA showed a specificity of up to 100%. The LSD IGRA could be a powerful immunoassay for early detection of LSD and post-vaccination monitoring, making it worthwhile to explore its diagnostic characteristics in more animals and under field conditions.IMPORTANCEThe immune reaction to lumpy skin disease virus (LSDV) infection or vaccination is currently assessed with serological tests prone to suboptimal sensitivity, long processing time, and the necessity of biosafety level (BSL) 3 laboratories. Furthermore, the delayed or absent seroconversion indicates a need for an alternative immunoassay detecting immune reactions to LSDV exposure applicable in BSL2 settings. Seeing the known importance of cell-mediated immune (CMI) response against poxvirus infections, we evaluated the suitability of the interferon-gamma release assay (IGRA) test for detection of LSDV infection and vaccination. IGRA allowed early detection of the CMI response to LSDV infection (within 7 days) and vaccination (within 10 days) with a Neethling-based live attenuated vaccine, and the CMI response preceded the detection of seroconversion. Whole blood and heat-inactivated antigen increased IGRA sensitivity, making it suitable for application in BSL2 laboratories. This assay overcomes the downsides of currently available immunoassays, and these results encourage its further evaluation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.